📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Cardiokine

1.1 - Company Overview

Cardiokine Logo

Cardiokine

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of specialty pharmaceutical development for the prevention and treatment of cardiovascular diseases, including lixivaptan, an orally active vasopressin receptor antagonist for congestive heart failure patients with hyponatremia.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Cardiokine

Bolt Medical Logo

Bolt Medical

HQ: United States Website
  • Description: Provider of investigational medical devices for calcified arterial lesions, including Bolt IVLTM/Bolt IVL intravascular lithotripsy using laser-based acoustic pressure waves for coronary and peripheral arteries; RESTORE ATK/BTK systems for peripheral arterial disease above/below the knee; and the RESTORE FIH Coronary System, all under clinical evaluation.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Bolt Medical company profile →
Polares Medical Logo

Polares Medical

HQ: United States Website
  • Description: Provider of a novel medical device for treating mitral valve regurgitation, designed to address the condition in which the heart’s mitral valve does not close tightly, allowing blood to flow backward.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Polares Medical company profile →
VIA Pharmaceuticals Logo

VIA Pharmaceuticals

HQ: United States Website
  • Description: Provider of biotechnology solutions focused on developing small-molecule drugs to treat cardiovascular diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full VIA Pharmaceuticals company profile →
CinCor Pharma Logo

CinCor Pharma

HQ: United States Website
  • Description: Provider of clinical-stage biopharmaceutical research and development focused on cardiovascular, metabolic, and kidney diseases, advancing promising clinical candidates toward marketing approval, including CIN-107, a novel aldosterone synthase inhibitor.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full CinCor Pharma company profile →
Semler Scientific Logo

Semler Scientific

HQ: United States Website
  • Description: Provider of medical risk-assessment solutions, including QuantaFlo software for non-invasive vascular disease risk assessment by evaluating extremity blood flow; SemlerShield for protection and security of medical data; SemlerVault for secure storage of sensitive medical information; SemlerAnalytics for insights and analytics on medical data; and SemlerSimulation, an online simulation-based training program for medical professionals.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Semler Scientific company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Cardiokine

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Cardiokine

2.2 - Growth funds investing in similar companies to Cardiokine

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Cardiokine

4.2 - Public trading comparable groups for Cardiokine

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Cardiokine

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Cardiokine

What does Cardiokine do?

Cardiokine is a provider of specialty pharmaceutical development for the prevention and treatment of cardiovascular diseases, including lixivaptan, an orally active vasopressin receptor antagonist for congestive heart failure patients with hyponatremia.

Who are Cardiokine's competitors?

Cardiokine's competitors and similar companies include Bolt Medical, Polares Medical, VIA Pharmaceuticals, CinCor Pharma, and Semler Scientific.

Where is Cardiokine headquartered?

Cardiokine is headquartered in United States.

How many employees does Cardiokine have?

Cardiokine has 1,000 employees 🔒.

When was Cardiokine founded?

Cardiokine was founded in 2010 🔒.

What sector and industry vertical is Cardiokine in?

Cardiokine is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Cardiokine

Who are the top strategic acquirers in Cardiokine's sector and industry

Top strategic M&A buyers and acquirers in Cardiokine's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Cardiokine?

Top strategic M&A buyers groups and sectors for Cardiokine include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Cardiokine's sector and industry vertical

Which are the top PE firms investing in Cardiokine's sector and industry vertical?

Top PE firms investing in Cardiokine's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Cardiokine's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Cardiokine's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Cardiokine's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Cardiokine include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Cardiokine's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Cardiokine?

The key public trading comparables and valuation benchmarks for Cardiokine include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Cardiokine for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Cardiokine with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Cardiokine's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Cardiokine with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Cardiokine's' sector and industry vertical?

Access recent funding rounds and capital raises in Cardiokine's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Cardiokine